Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
Fresenius Kabi is looking for in-licensing opportunities in infusion therapy and clinical nutrition, e.g. in the area of i.v. drugs, more specifically in the areas of pain management/CNS, anesthesia, anti-infectives, inflammation and oncology. More
Acquisition of established pharmaceuticals in the UK market More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Therapeutic drugs in late stage development (marketed, registered or in clinical trials) are sought to complement our product portfolio. More
GOODLIFE Healthcare is looking for in-licensing opportunities in psychiatry More
Products for smoking cessation More
Azur is interested in late stage or marketed products for the US market More
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- CNS trauma
- Diabetic neuropathy
- Fibromyalgia
- Muscular dystrophy
- Myasthenia gravis
- Peripheral neuropathy
- Sexual dysfunction
- Smoking cessation
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us